Comorbid Insomnia with Anxiety
Conditions
Interventions
Control group:Oral Lorazepam
Treatment group:Auriculotherapy
Comprehensive Group:Oral Lorazepam and Auriculotherapy
Sponsors
Beijing No.6 Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Meets the diagnostic criteria for insomnia and anxiety disorders in Western medicine, and meets the diagnostic criteria for insomnia in Traditional Chinese Medicine (TCM). (2) Aged between 18 and 65 years, inclusive. (3) Voluntarily agrees to participate in the study and signs the informed consent form. (4) No use of other Chinese or Western medications or treatment interventions within the past month. (5) Pittsburgh Sleep Quality Index (PSQI) score > 10, Hamilton Anxiety Rating Scale (HAMA) score between 7 (inclusive) and 29, and 17-item Hamilton Depression Rating Scale (HAMD) score < 7.
Exclusion criteria
Exclusion criteria: (1) Coexistence of other mental disorders. (2) Coexistence of severe heart, brain, liver, kidney, or thyroid diseases. (3) Pregnant or breastfeeding women. (4) Known allergy to the investigational drug. (5) Has contraindications for magnetic resonance imaging (MRI).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index efficiency;Hamilton Anxiety Scale efficiency;Athens Insomnia Scale efficiency;Sleep Hygiene Habits Scale efficiency;Generalized Anxiety Disorder Scale efficiency; | — |
Secondary
| Measure | Time frame |
|---|---|
| Average Diffusion Coefficient;Fractional Anisotropy; | — |
Countries
China
Contacts
Public ContactLin Yushun
Beijing No.6 Hospital
Outcome results
None listed